CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- 4 Open-market sale General Counsel sold 10,800 shares at $7.42 ($80,146)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- 424B5 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- CORRESP Other Correspondence Between Filers and SEC Staff
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 4 Other disposition Director disposed of 3,473,543 shares (other)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
Page 17 of 22 · 423 filings